Substitutions of Ser83Leu in GyrA and Ser80Leu in ParC Associated with Quinolone Resistance in Acinetobacter pittii

Microbial Drug Resistance

Volumn 21, Issue 3, 2015, Pages 345-351

  Gu, Dan Xia ^a   Hu, Yun Jian ^b   Zhou, Hong Wei ^a   Zhang, Rong ^a   Chen, Gong Xiang ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b BEIJING HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A; DNA TOPOISOMERASE (ATP HYDROLYSING) B; ENOXACIN; GATIFLOXACIN; LEVOFLOXACIN; LOMEFLOXACIN; MOXIFLOXACIN; NALIDIXIC ACID; OFLOXACIN; PROTEIN PARC; PROTEIN PARE; QUINOLONE; RNA POLYMERASE BETA SUBUNIT; SPARFLOXACIN; ANTIINFECTIVE AGENT; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE IV; QUINOLONE DERIVATIVE;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ACINETOBACTER CALCOACETICUS; ACINETOBACTER NOSOCOMIALIS; ACINETOBACTER PITTII; AGAR DILUTION; AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CHINA; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MIC50; MIC90; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID MEDIATED QUINOLONE RESISTANCE; PRIORITY JOURNAL; ACINETOBACTER INFECTIONS; BACTERIAL CHROMOSOME; CHEMISTRY; DNA SEQUENCE; DRUG EFFECTS; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MUTATION; PLASMID; POLYMERASE CHAIN REACTION;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ACINETOBACTER CALCOACETICUS;

ACINETOBACTER; ACINETOBACTER INFECTIONS; AMINO ACID SUBSTITUTION; ANTI-BACTERIAL AGENTS; CHROMOSOMES, BACTERIAL; DNA GYRASE; DNA TOPOISOMERASE IV; DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION; PLASMIDS; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

EID: 84930240944     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2014.0057     Document Type: Article

References (40)

1. Cavaco, L.M., H. Hasman, S. Xia, and F.M. Aarestrup. 2009. qnrD, a novel gene conferring transferable quinolone resistance in Salmonella enterica serovar Kentucky and Bovismorbificans strains of human origin. Antimicrob. Agents Chemother. 53:603-608.
2. Clinical and Laboratory Standards Institute. 2013. Performance Standards for Antimicrobial Susceptibility Testing; twenty-third informational supplement M100-S23, vol. 33, no. 1. Clinical and Laboratory Standards Institute, Wayne, PA.
3. Dijkshoorn, L., A. Nemec, and H. Seifert. 2007. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat. Rev. Microbiol. 5:939-951.
4. Donnarumma, F., S. Sergi, C. Indorato, G. Mastromei, R. Monnanni, P. Nicoletti, P. Pecile, D. Cecconi, R. Mannino, S. Bencini, R. Fanci, A. Bosi, and E. Casalone. 2010. Molecular characterization of Acinetobacter isolates collected in intensive care units of six hospitals in Florence, Italy, during a 3-year surveillance program: a population structure analysis. J. Clin. Microbiol. 48:1297-1304.
5. Eaves, D.J., L. Randall, D.T. Gray, A. Buckley, M.J. Woodward, A.P. White, and L.J. Piddock. 2004. Prevalence of mutations within the quinolone resistance-determining region of gyrA, gyrB, parC and parE and association with antibiotic resistance in quinolone-resistant Salmonella enterica. Antimicrob. Agents Chemother. 48:4012-4015.
6. Espinal, P., I. Roca, and J. Vila. 2011. Clinical impact and molecular basis of antimicrobial resistance in non-baumannii Acinetobacter. Future Microbiol. 6:495-511.
7. Hansen, L.H., L.B. Jensen, H.I. Sorensen, and S.J. Sorensen. 2007. Substrate specificity of the OqxAB multidrug resistance pump in Escherichia coli and selected enteric bacteria. J. Antimicrob. Chemother. 60:145-147.
8. Horrevorts, A., K. Bergman, L. Kollee, I. Breuker, I. Tjernberg, and L. Dijkshoorn. 1995. Clinical and epidemiological investigations of Acinetobacter genomospecies 3 in a neonatal intensive care unit. J. Clin. Microbiol. 33:1567-1572.
9. Hu, Y.Y., J.C. Cai, H.W. Zhou, D. Chi, X.F. Zhang, W.L. Chen, R. Zhang, and G.X. Chen. 2013. Molecular typing of CTX-M-producing Escherichia coli isolates from environmental water, swine feces, specimens from healthy humans, and human patients. Appl. Environ. Microbiol. 79:5988-5996.
10. Jiang, X., T. Yu, X. Jiang, W. Zhang, L. Zhang, and J. Ma. 2014. Emergence of plasmid-mediated quinolone resistance genes in clinical isolates of Acinetobacter baumannii and Pseudomonas aeruginosa in Henan, China. Diagn. Microbiol. Infect. Dis. 79:381-383.
11. Jiang, Y., Z. Zhou, Y. Qian, Z. Wei, Y. Yu, S. Hu, and L. Li. 2008. Plasmid-mediated quinolone resistance determinants qnr and aac(6′)-Ib-cr in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in China. J. Antimicrob. Chemother. 61:1003-1006.
12. Karah, N., B. Haldorsen, K. Hegstad, G.S. Simonsen, A. Sundsfjord, and O. Samuelsen. 2011. Species identification and molecular characterization of Acinetobacter spp. blood culture isolates from Norway. J. Antimicrob. Chemother. 66:738-744.
13. Komp Lindgren, P., A. Karlsson, and D. Hughes. 2003. Mutation rate and evolution of fluoroquinolone resistance in Escherichia coli isolates from patients with urinary tract infections. Antimicrob. Agents Chemother. 47:3222-3232.
14. La Scola B., V.A. Gundi, A. Khamis, and D. Raoult. 2006. Sequencing of the rpoB gene and flanking spacers for molecular identification of Acinetobacter species. J. Clin. Microbiol. 44:827-832.
15. Lee, Y.C., Y.T. Huang, C.K. Tan, Y.W. Kuo, C.H. Liao, P.I. Lee, and P.R. Hsueh. 2011. Acinetobacter baumannii and Acinetobacter genospecies 13TU and 3 bacteraemia: comparison of clinical features, prognostic factors and outcomes. J. Antimicrob. Chemother. 66:1839-1846.
16. Lim, Y.M., K.S. Shin, and J. Kim. 2007. Distinct antimicrobial resistance patterns and antimicrobial resistance-harboring genes according to genomic species of Acinetobacter isolates. J. Clin. Microbiol. 45:902-905.
17. Lin, Y.C., W.H. Sheng, Y.C. Chen, S.C. Chang, K.C. Hsia, and S.Y. Li. 2010. Differences in carbapenem resistance genes among Acinetobacter baumannii, Acinetobacter genospecies 3 and Acinetobacter genospecies 13TU in Taiwan. Int. J. Antimicrob. Agents 35:439-443.
18. Liu, B.T., X.M. Wang, X.P. Liao, J. Sun, H.Q. Zhu, X.Y. Chen, and Y.H. Liu. 2011. Plasmid-mediated quinolone resistance determinants oqxAB and aac(6′)-Ib-cr and extended-spectrum beta-lactamase gene blaCTX-M-24 colocated on the same plasmid in one Escherichia coli strain from China. J. Antimicrob. Chemother. 66:1638-1639.
19. Liu, Y.H., S.C. Kuo, Y.T. Lee, I.C. Chang, S.P. Yang, T.L. Chen, and C.P. Fung. 2012. Amino acid substitutions of quinolone resistance determining regions in GyrA and ParC associated with quinolone resistance in Acinetobacter baumannii and Acinetobacter genomic species 13TU. J. Microbiol. Immunol. Infect. 45:108-112.
20. Ma, J., Z. Zeng, Z. Chen, X. Xu, X. Wang, Y. Deng, D. Lu, L. Huang, Y. Zhang, J. Liu, and M. Wang. 2009. High prevalence of plasmid-mediated quinolone resistance determinants qnr, aac(6′)-Ib-cr, and qepA among ceftiofur-resistant Enterobacteriaceae isolates from companion and food-producing animals. Antimicrob. Agents Chemother. 53:519-524.
21. Martinez-Martinez, L., A. Pascual, and G.A. Jacoby. 1998. Quinolone resistance from a transferable plasmid. Lancet 351:797-799.
22. Petersen, K., S.C. Cannegieter, T.J. van der Reijden, B. van Strijen, D.M. You, B.S. Babel, A.I. Philip, and L. Dijkshoorn. 2011. Diversity and clinical impact of Acinetobacter baumannii colonization and infection at a military medical center. J. Clin. Microbiol. 49:159-166.
23. Robicsek, A., J. Strahilevitz, G.A. Jacoby, M. Macielag, D. Abbanat, C.H. Park, K. Bush, and D.C. Hooper. 2006. Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat. Med. 12:83-88.
24. Seifert, H., R. Baginski, A. Schulze, and G. Pulverer. 1993. The distribution of Acinetobacter species in clinical culture materials. Zentralbl. Bakteriol. 279:544-552.
25. Shaheen, B.W., R. Nayak, S.L. Foley, and D.M. Boothe. 2013. Chromosomal and plasmid-mediated fluoroquinolone resistance mechanisms among broad-spectrum-cephalosporin-resistant Escherichia coli isolates recovered from companion animals in the USA. J. Antimicrob. Chemother. 68:1019-1024.
26. Sorlozano, A., J. Gutierrez, A. Jimenez, J. de Dios Luna, and J.L. Martinez. 2007. Contribution of a new mutation in parE to quinolone resistance in extended-spectrum-beta-lactamase-producing Escherichia coli isolates. J. Clin. Microbiol. 45:2740-2742.
27. Touati, A., L. Brasme, S. Benallaoua, A. Gharout, J. Madoux, and C. De Champs. 2008. First report of qnrB-producing Enterobacter cloacae and qnrA-producing Acinetobacter baumannii recovered from Algerian hospitals. Diagn. Microbiol. Infect. Dis. 60:287-290.
28. Tran, J.H., and G.A. Jacoby. 2002. Mechanism of plasmid-mediated quinolone resistance. Proc. Natl. Acad. Sci. U. S. A. 99:5638-5642.
29. Turton, J.F., J. Shah, C. Ozongwu, and R. Pike. 2010. Incidence of Acinetobacter species other than A. baumannii among clinical isolates of Acinetobacter: evidence for emerging species. J. Clin. Microbiol. 48:1445-1449.
30. Turton, J.F., N. Woodford, J. Glover, S. Yarde, M.E. Kaufmann, and T.L Pitt. 2006. Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. J. Clin. Microbiol. 44:2974-2976.
31. van Dessel, H., T.E. Kamp-Hopmans, A.C. Fluit, S. Brisse, A.M. de Smet, L. Dijkshoorn, A.Troelstra, J. Verhoef, and E.M. Mascini. 2002. Outbreak of a susceptible strain of Acinetobacter species 13 (sensu Tjernberg and Ursing) in an adult neurosurgical intensive care unit. J. Hosp. Infect. 51:89-95.
32. Vila, J., J. Ruiz, P. Goni, and T. Jimenez de Anta. 1997. Quinolone-resistance mutations in the topoisomerase IV parC gene of Acinetobacter baumannii. J. Antimicrob. Chemother. 39:757-762.
33. Vila, J., J. Ruiz, P. Goni, A. Marcos, and T. Jimenez de Anta. 1995. Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumannii. Antimicrob. Agents. Chemother. 39:1201-1203.
34. Vincent, J.L., J. Rello, J. Marshall, E. Silva, A. Anzueto, C.D. Martin, R. Moreno, J. Lipman, C. Gomersall, Y. Sakr, K. Reinhart, and EPIC II Group of Investigators. 2009. International study of the prevalence and outcomes of infection in intensive care units. JAMA 302:2323-2329.
35. Wang, M., Q. Guo, X. Xu, X. Wang, X. Ye, S. Wu, D.C. Hooper, and M. Wang. 2009. New plasmid-mediated quinolone resistance gene, qnrC, found in a clinical isolate of Proteus mirabilis. Antimicrob. Agents Chemother. 53:1892-1897.
36. Weigel, L.M., G.J. Anderson, and F.C. Tenover. 2002. DNA gyrase and topoisomerase IV mutations associated with fluoroquinolone resistance in Proteus mirabilis. Antimicrob. Agents Chemother. 46:2582-2587.
37. Wisplinghoff, H. 2002. Mutations in gyrA and parC associated with resistance to fluoroquinolones in epidemiologically defined clinical strains of Acinetobacter baumannii. J. Antimicrob. Chemother. 51:177-180.
38. Xi, H.M., Y. Xu, D.M. Zhu, F. Wang, Y.X. Ni, J.Y. Sun, C. Jian, Y.J. Hu, X.M. Ai, H. Zhang, W.H. Li, B. Jiang, W.X. Huang, C.Q. Wang, A.M. Wang, L.H. Wei, L. Wu, C. Zhuo, D.H. Su, Z.X. Zhang, P. Ji, Y.H. Xu, Z.Z. Xiong, J.L. Shen, B. Shan, Y. Du, Y. Yu, and Q. Yang. 2012. CHINET 2010 surveillance of antibiotic resistance in Acinetobacter baumannii in China. Chin. J. Infect. Chemother. 12:98-104.
39. Yamane, K., J. Wachino, S. Suzuki, K. Kimura, N. Shibata, H. Kato, K. Shibayama, T. Konda, and Y. Arakawa. 2007. New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate. Antimicrob. Agents Chemother. 51:3354-3360.
40. Zhang, R., T. Ichijo, Y.-L. Huang, J.C. Cai, H.W. Zhou, N. Yamaguchi, M. Nasu, and G.X. Chen. 2012. High prevalence of qnr and aac(6′)-Ib-cr genes in both waterborne environmental bacteria and clinical isolates of Citrobacter freundii in China. Microb. Environ. 27:158-163.